Caremark Pharmacy - Search News

Pharmacy benefit managers inflated drug prices by $7.3B

Healthcare Dive · 1d

FTC releases second report slamming pharmacy benefit managers

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer — but relies on more data.

FOX 9 Minneapolis-St. Paul on M… · 1d

FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%

Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of creating pharmacy deserts by steering consumers to their own pharmacies and driving independent pharmacists out of business.

USA Today · 20h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

Axios on MSN2h

Mass. files suit accusing insulin makers of price-gouging

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

17hon MSN

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%

The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...

Healthcare Dive7d

CVS successfully converts commercial pharmacy contracts to “cost plus” model

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results